Company / Cash per Share
BioAge Labs, Inc. Cash per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$5.27
FY2025
5-year range
$5.27 / $33.03
FY2023-FY2025
Trend
-84.1%
vs FY2024
Sector context
#40 of 205
Health Care
What the data says
BioAge Labs, Inc.'s cash per share of $5.27 is higher than 80% of companies in the Health Care sector (FY2025). Declined from $12.94 to $5.27 over the past 2 years.
Based on SEC 10-K filings.
5.27 in FY2025. Top quartile in the Health Care sector.
Declined from $12.94 to $5.27 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 205This company $5.27 Sector average $72.93
▼
-92.8% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 84.1% year-over-year.
- Ranks #40 out of 205 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.75 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.27 | -84.1% |
| FY2024 | $33.03 | +155.3% |
| FY2023 | $12.94 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026